S

SeaStar Medical Holding Corp
NASDAQ:ICU

Watchlist Manager
SeaStar Medical Holding Corp
NASDAQ:ICU
Watchlist
Price: 4.13 USD -2.59%
Market Cap: $16.5m

SeaStar Medical Holding Corp
Other Non-Cash Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

SeaStar Medical Holding Corp
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
S
SeaStar Medical Holding Corp
NASDAQ:ICU
Other Non-Cash Items
$908k
CAGR 3-Years
-58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Other Non-Cash Items
$522m
CAGR 3-Years
-1%
CAGR 5-Years
77%
CAGR 10-Years
N/A
Edwards Lifesciences Corp
NYSE:EW
Other Non-Cash Items
$332.2m
CAGR 3-Years
14%
CAGR 5-Years
23%
CAGR 10-Years
32%
Stryker Corp
NYSE:SYK
Other Non-Cash Items
$586m
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Other Non-Cash Items
$729m
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
4%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Non-Cash Items
$730m
CAGR 3-Years
9%
CAGR 5-Years
16%
CAGR 10-Years
13%
No Stocks Found

SeaStar Medical Holding Corp
Glance View

Market Cap
16.5m USD
Industry
Health Care

Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company is headquartered in Tampa, Florida. The company went IPO on 2021-01-26. The firm is focused on redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. The firm's technologies rely on science to provide life-saving solutions to critically ill patients. The firm is engaged in developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

ICU Intrinsic Value
1.35 USD
Overvaluation 67%
Intrinsic Value
Price $4.13
S

See Also

What is SeaStar Medical Holding Corp's Other Non-Cash Items?
Other Non-Cash Items
908k USD

Based on the financial report for Dec 31, 2025, SeaStar Medical Holding Corp's Other Non-Cash Items amounts to 908k USD.

What is SeaStar Medical Holding Corp's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 3Y
-58%

Over the last year, the Other Non-Cash Items growth was -88%. The average annual Other Non-Cash Items growth rates for SeaStar Medical Holding Corp have been -58% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett